Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML
Clinical trial NCT00416884 · TERMINATED
Trial details
- NCT number
- NCT00416884
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2008-03-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.